Risk factors and prognostic impact of left ventricular assist device–associated infections
Authors:
- 1 August 2019
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 214, 69-76
Abstract
No abstract availableKeywords
Funding Information
- Fédération Française de Cardiologie
This publication has 28 references indexed in Scilit:
- Cardiovascular Implantable Electronic Device Infections in Left Ventricular Assist Device RecipientsPacing and Clinical Electrophysiology, 2013
- Clinical Manifestations and Management of Left Ventricular Assist Device-Associated InfectionsClinical Infectious Diseases, 2013
- Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011The Journal of Thoracic and Cardiovascular Surgery, 2013
- Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure, 2013
- Prospective, Multicenter Study of Ventricular Assist Device InfectionsCirculation, 2013
- Driveline Infections in Left Ventricular Assist Devices: Implications for Destination TherapyThe Annals of Thoracic Surgery, 2012
- Left Ventricular Assist Device–Associated InfectionsInfectious Disease Clinics of North America, 2012
- Working formulation for the standardization of definitions of infections in patients using ventricular assist devicesThe Journal of Heart and Lung Transplantation, 2011
- Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow EraThe Annals of Thoracic Surgery, 2010
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001